CBD vape liquid is heated up and inhaled as a vapor. Using CBD in this way provides maximum bioavailability as it absorbs lung tissue quickly and efficiently.
So, how can CBD help, and what’s the best type of CBD for preventing congestive heart failure (CHF)?
This type of CBD is the most valuable to use for multiple health conditions and holds the most potential for preventing congestive heart failure. This is because it provides the full entourage effect.
Congestive heart failure, also known simply as heart failure, occurs when the heart cannot pump enough blood around the body.
Coronary artery disease is the most common type of heart disease. The arteries that supply blood to the heart can become clogged with plaque, causing them to narrow and reduce the efficiency of the heart.
It’s important to note that these symptoms do match up with other conditions and are considered normal in some circumstances.
In short, yes CBD can help prevent congestive heart failure.
CFN Media’s Cannabis Financial Network (CannabisFN.com) is the destination for savvy investors and business people profiting from the worldwide cannabis industry. Viewers will see breaking news, exclusive content and original programming involving the people, companies and investments shaping the industry.
Heart failure (HF) affects more than 6 million adults in Canada and the United States and is a leading cause of hospitalization, with costs exceeding $30 billion each year in the US alone. People with HF suffer from shortness of breath, rapid heart rate, edema, reduced exercise capacity, often struggle with simple daily activities, and are frequently hospitalized. For many, these symptoms significantly reduce quality of life.
There is great upside potential for Cardiol as the company advances its therapies for the treatment of HF. Concurrently, the company is advancing its immunotherapeutic for the treatment of GBM, the most frequent and deadliest form of cancer affecting the brain. Treatments in the US for GBM are eligible for orphan drug status, meaning clinical research is subject to Fast Track review, with the intent of getting successful treatments to market as quickly as possible.
There is, however, considerable research indicating that cannabidiol, or CBD, has potent anti-inflammatory and anti-fibrotic properties that could prove beneficial for treating HFpEF. Derived from the hemp or cannabis plant, CBD is getting a lot of attention as researchers are finally able to legally study the molecule. One issue with CBD lies with its delivery, due to CBD’s hydrophobic nature. If taken orally, the liver removes much of the CBD before it enters the bloodstream, with the result that most current treatments involve very high and imprecise dosing.
Cardiol has developed a unique patented system whereby lipophilic (fat soluble) drugs like CBD, are encased in a hydrophilic (water soluble) shell. This shell allows the active lipophilic ingredient to effectively circulate in the bloodstream. Normally, taking CBD orally results in less than 10% bioavailability, due to “first-pass” metabolism by the liver. Cardiol’s nanotherapeutics delivery methodology, which avoids the oral route, allows for much higher levels of lipophilic active ingredients in the bloodstream and, most importantly, has the potential to deliver drugs to specific sites of inflammation in the body. This proprietary technology could be licensed or partnered with other companies. Furthermore, the opportunity here is not just limited to CBD delivery, as these same problems have vexed companies developing other lipophilic drugs.
Cardiol Therapeutics is a biotech company with a strong background in heart therapy research, a proven and patented nanotechnology solution for the targeted delivery of CBD and other lipophilic drugs to inflamed tissues, and a supplier of ultra-pure pharmaceutical CBD to further its research into the treatment of HFpEF. Cardiol is also advancing an immunotherapeutic for the treatment of glioblastoma multiforme (GBM), the deadly brain cancer that took the lives of Senators Ted Kennedy and John McCain. The company believes a combination of cannabinoids and cell-based immunotherapies shows great promise in the treatment of GBM. Cardiol will soon be launching its ultra-pure pharmaceutical CBD oil into the Canadian medical market, a move the company hopes will generate significant revenue in the short term.
Our powerful digital media and distribution platform conveys a company’s message and value proposition directly to accredited and retail investors and national media active in the North American cannabis markets.
CBD oil is now being used to prevent and slow atherosclerosis, due to the role that the endocannabinoid system plays in its pathogenesis. Deficiencies in the endocannabinoid system affect the health of the arteries, leading to the hardening and narrowing that characterises atherosclerosis.
CBD has been shown to limit the effects of complications of CHF, including heart arrhythmia. It also targets arteries for isolated action, produces vasorelaxation, and prevents damage due to ischemia-reperfusion.
Studies now indicate that CBD oil is effective in treating atherosclerosis. It is a useful addition to current treatment options, and goes hand in hand with the healthy eating and lifestyle changes.
CBD and Heart Health
Use CBD oil for the maintenance of your heart health and recovery from heart disease. It will also lessen the impact of atherosclerosis and congestive heart failure, improving the health of your heart in the long term.
Preliminary research suggests that CBD may help with the blockage of arteries caused by arterial plaque, a conditional known as atherosclerosis. Patients with high “bad” cholesterol may especially benefit from this effect of CBD on heart health.
The best CBD oil for preventing heart disease is an oral tincture. It can be taken twice daily as a supplement. For an in-depth look at your product options, check out our ranking of the best CBD oils for preventing heart disease.
With such grim statistics on heart disease, any promising new treatment is a valuable resource. And a promising, all-natural, safe, affordable, side-effect-free, and prescription-free treatment, needless to say, is better still. That’s exactly what the use of CBD for heart disease offers, and the reason that CBD has been so quickly gaining popularity, as cardio patients look for ways they can enhance their program of conventional medicine, exercise routines and heart healthy diets. While the body of scientific knowledge about the effects of CBD on heart health is still small, the results so far show that CBD may be an extremely potent weapon in the fight against heart disease, acting on several fronts to improve cardiovascular health: